CAH250502C137000
- 12.56
- 0.000.00%
Cardinal Health Newsroom
Cardinal Health Releases New Report on the Cell and Gene Therapy Industry
Express News | Charles River Laboratories Agrees to Add Four New Directors, Review Business in Settlement With Activist Investor Elliott, Sources Say
Cardinal Health To Go Ex-Dividend On July 1st, 2025 With 0.5107 USD Dividend Per Share
Recent Dividend Declarations
New Analyst Forecast: $CAH Given 'Overweight' Rating
Argus Research Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $162
'Trump To Sign Order To Encourage Domestic Drug Manufacturing' - Washington Post
Cardinal Health Raises Dividend by About 1%
Express News | Cardinal Health Inc - Board Approves Dividend Increase to $0.5107 per Share
Press Release: Cardinal Health Board of Directors Approves Quarterly Dividend
Cardinal Health Is Maintained at Overweight by Morgan Stanley
Research Alert: CFRA Maintains Buy Opinion On Shares Of Cardinal Health
Argus Adjusts Price Target on Cardinal Health to $162 From $148
Today's Analyst Rating | Berkshire Hathaway-A Price Target Raised to $909218 by UBS, BofA Securities Cuts Its Price Target Cut on Oracle to $156
Morgan Stanley Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $166
Express News | Cardinal Health Inc : Deutsche Bank Raises Target Price to $148 From $131
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amgen (AMGN), Organon (OGN) and Cardinal Health (CAH)
Cardinal Health's Promising Growth Under New Leadership Justifies Buy Rating
Evercore ISI Sticks to Its Buy Rating for Cardinal Health (CAH)
Cardinal Health Third Quarter 2025 Earnings: EPS Beats Expectations